These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 12622346)

  • 1. Repeated spatial acquisition: effects of NMDA antagonists and morphine.
    Galizio M; Keith JR; Mansfield WJ; Pitts RC
    Exp Clin Psychopharmacol; 2003 Feb; 11(1):79-90. PubMed ID: 12622346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of positive GABA(A) modulators on a multiple-component, repeated-acquisition test of spatial learning.
    Keith JR; Pitts RC; Pezzuti T; Galizio M
    Behav Pharmacol; 2003 Feb; 14(1):67-75. PubMed ID: 12576883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of N-methyl-D-aspartate receptor antagonists on acute morphine-induced and l-methadone-induced antinociception in mice.
    Fischer BD; Carrigan KA; Dykstra LA
    J Pain; 2005 Jul; 6(7):425-33. PubMed ID: 15993820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of intrathecal NMDA and non-NMDA antagonists on acute thermal nociception and their interaction with morphine.
    Nishiyama T; Yaksh TL; Weber E
    Anesthesiology; 1998 Sep; 89(3):715-22. PubMed ID: 9743410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The competitive NMDA receptor antagonist LY235959 modulates the progression of morphine tolerance in rats.
    Allen RM; Dykstra LA
    Psychopharmacology (Berl); 1999 Feb; 142(2):209-14. PubMed ID: 10102774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention by morphine of N-methyl-D-aspartic acid-induced penile erection and yawning: involvement of nitric oxide.
    Melis MR; Succu S; Argiolas A
    Brain Res Bull; 1997; 44(6):689-94. PubMed ID: 9421131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of glutamate receptor antagonists on place aversion induced by naloxone in single-dose morphine-treated rats.
    Kawasaki Y; Jin C; Suemaru K; Kawasaki H; Shibata K; Choshi T; Hibino S; Gomita Y; Araki H
    Br J Pharmacol; 2005 Jul; 145(6):751-7. PubMed ID: 15880144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antinociceptive effect of combined systemic administration of morphine and the glycine/NMDA receptor antagonist, (+)-HA966 in a rat model of peripheral neuropathy.
    Christensen D; Idänpään-Heikkilä JJ; Guilbaud G; Kayser V
    Br J Pharmacol; 1998 Dec; 125(8):1641-50. PubMed ID: 9886755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-methyl-D-aspartate receptor antagonists potentiate the antinociceptive effects of morphine in squirrel monkeys.
    Allen RM; Dykstra LA
    J Pharmacol Exp Ther; 2001 Jul; 298(1):288-97. PubMed ID: 11408554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of NMDA receptor antagonists on acute mu-opioid analgesia in the rat.
    Redwine KE; Trujillo KA
    Pharmacol Biochem Behav; 2003 Sep; 76(2):361-72. PubMed ID: 14592689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NMDA antagonist modulation of morphine antinociception in female vs. male rats.
    Craft RM; Lee DA
    Pharmacol Biochem Behav; 2005 Apr; 80(4):639-49. PubMed ID: 15820534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of (+)-HA-966, CGS-19755, phencyclidine, and dizocilpine on repeated acquisition of response chains in pigeons: systemic manipulation of central glycine sites.
    Campbell CM; Butelman ER; Woods JH
    J Pharmacol Exp Ther; 1999 Apr; 289(1):521-7. PubMed ID: 10087045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of NMDA receptor antagonists on inhibition of morphine tolerance in rats: binding at mu-opioid receptors.
    Wong CS; Cherng CH; Luk HN; Ho ST; Tung CS
    Eur J Pharmacol; 1996 Feb; 297(1-2):27-33. PubMed ID: 8851162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antinociceptive potentiation and attenuation of tolerance by intrathecal co-infusion of magnesium sulfate and morphine in rats.
    McCarthy RJ; Kroin JS; Tuman KJ; Penn RD; Ivankovich AD
    Anesth Analg; 1998 Apr; 86(4):830-6. PubMed ID: 9539610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of morphine maintenance dose in the development of tolerance and its attenuation by an NMDA receptor antagonist.
    Allen RM; Dykstra LA
    Psychopharmacology (Berl); 2000 Jan; 148(1):59-65. PubMed ID: 10663418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions between an N-methyl-D-aspartate antagonist and low-efficacy opioid receptor agonists in assays of schedule-controlled responding and thermal nociception.
    Fischer BD; Dykstra LA
    J Pharmacol Exp Ther; 2006 Sep; 318(3):1300-6. PubMed ID: 16772537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of reinforcing effects of morphine and naloxone-precipitated opioid withdrawal by novel glycine site and uncompetitive NMDA receptor antagonists.
    Popik P; Mamczarz J; Fraczek M; Widła M; Hesselink M; Danysz W
    Neuropharmacology; 1998 Aug; 37(8):1033-42. PubMed ID: 9833632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats.
    Stinus L; Cador M; Zorrilla EP; Koob GF
    Neuropsychopharmacology; 2005 Jan; 30(1):90-8. PubMed ID: 15138444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The NMDA receptor antagonist MK-801 differentially modulates mu and kappa opioid actions in spinal cord in vitro.
    Feng J; Kendig JJ
    Pain; 1996 Aug; 66(2-3):343-9. PubMed ID: 8880858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attenuation of mu-opioid tolerance and cross-tolerance by the competitive N-methyl-D-aspartate receptor antagonist LY235959 is related to tolerance and cross-tolerance magnitude.
    Allen RM; Dykstra LA
    J Pharmacol Exp Ther; 2000 Dec; 295(3):1012-21. PubMed ID: 11082436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.